# FDA Inspection 1180781 - Novum Pharmaceutical Research Services Inc - September 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/novum-pharmaceutical-research-services-inc/6e06f3a0-cefb-4f82-80f7-3bb61ed8d371
Source feed: FDA_Inspections

> FDA Inspection 1180781 for Novum Pharmaceutical Research Services Inc on September 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180781
- Company Name: Novum Pharmaceutical Research Services Inc
- Inspection Date: 2022-09-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1180916 - 2022-09-09](https://www.keypedia.com/records/fda_inspections/novum-pharmaceutical-research-services-inc/d907173b-35b3-475e-b636-5e11323d6dc6)
- [FDA Inspection 1080440 - 2019-02-01](https://www.keypedia.com/records/fda_inspections/novum-pharmaceutical-research-services-inc/679b291e-2364-4f92-8741-3fb7d39335ca)

Company: https://www.keypedia.com/companies/novum-pharmaceutical-research-services-inc/8b4e28fa-d1b9-4bf8-9f53-177e777878c0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c